Additionally, we assessed the allele frequencies of the genes in the gnomAD non-cancer cohort (n = 134 187), which showed significant differences in BRCA1, BRCA2, CHEK2, MUTYH, MSH6, POLE, and ERCC3 genes in comparison to our non-HBOC groups. This evidence concerns the gene ERCC3 and cancer.